Derivation of Huntington disease affected Genea020 human embryonic stem cell line

详细信息    查看全文

• 作者：Biljana Dumevska ; ^{biljana.dumevska@geneabiocells.com" class="auth_mail" title="E-mail the corresponding author} ; Teija Peura ; Robert McKernan ; Divya Goel ; Uli Schmidt
• 刊名：Stem Cell Research
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：16
• 期：2
• 页码：430-433
• 全文大小：777 K

文摘

The Genea020 human embryonic stem cell line was derived from a donated, fully commercially consented ART blastocyst, carrying Htt gene CAG expansion of 48 repeats, indicative of Huntington disease. Following ICM outgrowth on inactivated human feeders, karyotype was confirmed as 46, XX by CGH and STR analysis demonstrated a female allele pattern. The hESC line had pluripotent cell morphology, 89% of cells expressed Nanog, 95% Oct4, 29% Tra1-60 and 99% SSEA4, gave a Pluritest pluripotency score of 27.51, novelty of 1.43 and demonstrated alkaline phosphatase activity. The cell line was negative for Mycoplasma and visible contamination.